Intellectual property as a strategic focus

R

Rony Krysler, VP of Intellectual Property, Hobart Group

“Our group’s strategic approach for development and protection of our intellectual property is built on a foundational understanding that IP is amongst our greatest assets. We have developed a unique, multi-tiered IP strategy which aims to advance the group’s business goals and obtain a strong competitive advantage through offensive and defensive positions.”

Group companies and our founder have filed over 1,000 patents and patent applications, covering hundreds of inventions, in areas including cardiac contractility modulation, robotic rehabilitation and cardiac lesion assessment. Our inventors include:

d

David Prutchi, PhD

David Prutchi, who joined the group in 1997, holds an MSc and PhD in Biomedical Engineering from Tel-Aviv University.  He is the lead author of Design and Development of Medical Electronic Instrumentation – A Practical Perspective of the Design, Construction and Test of Medical Devices (Wiley-Interscience, 2004) and co-author of Exploring Quantum Physics Through Hands-On Projects (Wiley, 2012).

y

Yitzhack Schwartz, MD

Yitzhack Schwartz is a pediatrician and structural heart disease specialist with a special interest in harnessing novel technologies to solve unmet clinical needs. He is a graduate of the Technion ‒ Israel Institute of Technology and actively practiced medicine for 30 years. He holds over 40 issued patents and patent applications, and was a member of the Biosense-Webster (Johnson & Johnson) advanced R&D team.

Shlomo Ben-Haim, MD

Shlomo Ben-Haim, the founder of Hobart Group, is an entrepreneur in the field of medical technology with a long and successful record of exits. Educated in the fields of nuclear physics, mathematics, biophysics, philosophy and medicine, Professor Ben-Haim has held faculty appointments as Professor of Medicine, Physiology and Biophysics at Harvard University and the Technion ‒ Israel Institute of Technology.

s

Shawn Moaddeb, MSc

Shawn Moaddeb is an entrepreneur with over 25 years’ experience in the medical device industry. Shawn was VP of RF Technology at Vessix Vascular and he is a named inventor on over 100 issued and pending patents in the areas of RF catheter-based renal denervation, percutaneous mitral valve catheter-based therapy, electrophysiology and cardiac ablation systems, medical laser systems, GI, and implantable pacemaker and defibrillator devices.

Stay up to date